Shafigh Navid, Hasheminik Morteza, Khoundabi Batoul, Jamaati Hamidreza, Tabarsi Payam, Marjani Majid, Shafigh Elnaz, Malekmohammad Majid, Nooraei Navid, Hashemian Seyed Mohammad Reza
Clinical Research and Development Unit at Shahid Modarres Hospital, Department of Anesthesiology, Shahid Beheshti University of Medical Sciences, and Tehran, Iran.
Department of Nursing, Sabzevar Branch, Islamic Azad University, Sabzevar, Iran.
Tanaffos. 2023 Apr;22(4):433-439.
This study aims to investigate the clinical and demographic features of underlying medical conditions and the potential relationship between underlying diseases and the increased rate of morbidity and mortality due to COVID-19.
This study was conducted on 350 COVID-19 patients hospitalized at the Masih Daneshvari Hospital from February-July 2021. All participants had confirmed COVID-19 diagnosis based on symptoms and/or positive PCR test or chest X-ray results. Data was collected from medical records on demographics, disease severity, symptoms, underlying conditions like diabetes, hypertension, coronary heart disease, obesity, renal disease/transplantation, and outcomes like hospital stay, ICU admission, and mortality. Relationships between age, underlying diseases, and mortality were analyzed using chi-square and Fisher's exact tests."
A total of 350 patients diagnosed with COVID-19 were included in the study, with an average estimated age of (60.8±15.4). The age group of 56 and above had the highest morbidity rate, which accounted for 50% of the total participants. Among the COVID-19 patients, diabetes was the most common underlying medical condition, accounting for 31.4% of the cases. High blood pressure was present in 27.1% of the patients, and 17.1% of the total participants had coronary heart disease (CHD). Additionally, 10.9% of the participants were overweight, and 30 of them had previously experienced kidney failure or transplantation. Moreover, the study found that 40% of patients with diabetes died, while the mortality rate was 38.3% in patients with CHD and 47.4% in overweight participants. High blood pressure patients had a mortality rate of 43.2%, and patients with renal failure or kidney transplantation had a significantly increased risk of mortality at 83.3%. The research also revealed a significant and direct relationship between mortality rate, age group, and underlying disease among the patients (P<0.05).
The findings of the present study hold significant implications for preventive interventions and policy adoption, particularly in relation to the use of calendar age as the key criterion for risk evaluation. These results underscore the need for a more precise and focused approach to prioritizing patients with identified risk factors.
本研究旨在调查基础疾病的临床和人口统计学特征,以及基础疾病与新冠病毒疾病发病率和死亡率上升之间的潜在关系。
本研究对2021年2月至7月在马西·达内什瓦里医院住院的350例新冠病毒疾病患者进行。所有参与者均根据症状和/或聚合酶链反应检测阳性或胸部X光结果确诊为新冠病毒疾病。从病历中收集有关人口统计学、疾病严重程度、症状、基础疾病(如糖尿病、高血压、冠心病、肥胖症、肾脏疾病/移植)以及住院时间、重症监护病房收治情况和死亡率等结果的数据。使用卡方检验和费舍尔精确检验分析年龄、基础疾病与死亡率之间的关系。
本研究共纳入350例确诊为新冠病毒疾病的患者,平均估计年龄为(60.8±15.4)岁。56岁及以上年龄组的发病率最高,占总参与者的50%。在新冠病毒疾病患者中,糖尿病是最常见的基础疾病,占病例的31.4%。27.1%的患者患有高血压,17.1%的总参与者患有冠心病。此外,10.9%的参与者超重,其中30人曾经历过肾衰竭或移植。此外,研究发现糖尿病患者的死亡率为40%,冠心病患者的死亡率为38.3%,超重参与者的死亡率为47.4%。高血压患者的死亡率为43.2%,肾衰竭或肾脏移植患者的死亡风险显著增加,为83.3%。研究还揭示了患者死亡率、年龄组和基础疾病之间存在显著的直接关系(P<0.05)。
本研究结果对预防干预措施和政策制定具有重要意义,特别是在将日历年龄用作风险评估的关键标准方面。这些结果强调需要采取更精确、更有针对性的方法,对已确定风险因素的患者进行优先排序。